← All tickers

Is NUVB Worth Buying in 2026?

Nuvation Bio Inc.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-08-16

Here’s whether Nuvation Bio Inc. (NUVB) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+5.69% over 10 days); RSI 42 — healthy momentum range; strong 1-year return of +125.4%; 3-month momentum positive (+44.0%). Currently 36.2% off its 52-week high. Score: +7/7.

Ready to act on this? 📈 Trade on Webull

NUVB is in a confirmed uptrend, trading above both its 50-day ($5.88) and 200-day ($5.81) moving averages. An RSI of 41.5 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +125.4% compares to +20.4% for SPY (beat the market by 105.0%). The current 36.2% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $22,536 today
vs. S&P 500 (SPY) — same period beat market by 105.0%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✓Above 200-day MA ($5.81)
✓Above 50-day MA ($5.88)
✓RSI(14) neutral zone (30–70) — currently 41.5
✓Positive return (+125.4%)
!Within 10% of period high (−36.2%)
Period Range $6.22
$2.57 $9.75
RSI (14) 41.5
0 · OversoldOverbought · 100

Key Metrics

Price$6.22
Period Return+125.4%
Period High$9.75
Period Low$2.57
Drawdown−36.2%
MA-50$5.88
MA-200$5.81
RSI (14)41.5
Avg Volume (30d)6.3M
vs. SPYbeat by 105.0%
Return Rank#114 of 1252

Trade NUVB

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers